Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02653560 · ClinicalTrials.gov registry record · Phase 4
Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT02653560 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 30 participants.
The verdict
NCT02653560, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
In the DASH (Dietary Approaches to Stop Hypertension) trials, a diet rich in fruits, vegetables, nuts and dairy products, and limited in fat content, was shown to be useful in controlling hypertension. Key components of such a diet are potassium, magnesium and alkali, each of which has been implicated in lowering blood pressure. Whether a liquid formulation of potassium-magnesium citrate will result in equivalent BP effect as the DASH diet is unknown.
Interventions
- DRUG Placebo
- DRUG Potassium chloride powder
- DRUG Potassium magnesium Citrate (KMgCit)
- DRUG Potassium citrate powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-09 |
| Est. Completion | 2015-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02653560
The ClinicalTrials.gov registry entry for NCT02653560 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT02653560 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02653560 about?
NCT02653560 is a clinical study titled "Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension". In the DASH (Dietary Approaches to Stop Hypertension) trials, a diet rich in fruits, vegetables, nuts and dairy products, and limited in fat content, was shown to be useful in controlling hypertension. Key components of such a diet are potassium, magnesium and alkali, each of which has been implicat...
What is the current status of trial NCT02653560?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2012-09. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02653560?
The interventions under investigation include: Placebo (DRUG), Potassium chloride powder (DRUG), Potassium magnesium Citrate (KMgCit) (DRUG), Potassium citrate powder (DRUG).
Who is sponsoring clinical trial NCT02653560?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.